Predicting emergent Dolutegravir resistance in South Africa: A modelling study
View ORCID ProfileTom Loosli, Anthony Hauser, Johannes Josi, Nuri Han, Suzanne M Ingle, Ard van Sighem, Linda Wittkop, Janne Vehreschild, Francesca Ceccherini-Silberstein, Gary Maartens, M John Gill, Caroline A Sabin, Leigh F Johnson, Richard Lessells, Huldrych F Günthard, Matthias Egger, View ORCID ProfileRoger D Kouyos
doi: https://doi.org/10.1101/2024.07.20.24310740
Tom Loosli
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
MscAnthony Hauser
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
3Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
4INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
PhDJohannes Josi
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
PhDNuri Han
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
MscSuzanne M Ingle
5Population Health Sciences, Bristol Medical School, University of Bristol, UK
PhDArd van Sighem
6Stichting hiv monitoring, Amsterdam, the Netherlands
PhDLinda Wittkop
7Univ. Bordeaux, INSERM, Institut Bergonié BPH U1219, CIC-EC 1401, Bordeaux, F-33000, France
8INRIA SISTM Team, Talence, France
9CHU de Bordeaux, Service d’information Médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, F-33000, France
PhDRoles: Prof
Janne Vehreschild
10Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Frankfurt Am Main, Germany
11Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
12German Centre for Infection Research (DZIF), Partner Site Bonnl7lCologne, Cologne, Germany
MDRoles: Prof
Francesca Ceccherini-Silberstein
13Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy (Prof Francesca Ceccherini-Silberstein PhD)
PhDRoles: Prof
Gary Maartens
14Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa (Prof Gary Maartens MD)
MDRoles: Prof
M John Gill
15Southern Alberta Clinic, Calgary, AB, Canada
16Department of Medicine, University of Calgary, Calgary, AB, Canada
MDRoles: Prof
Caroline A Sabin
17Institute for Global Health, University College London, UK
PhDRoles: Prof
Leigh F Johnson
18Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa
PhDRoles: Prof
Richard Lessells
19KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa
20Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
PhDHuldrych F Günthard
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
MDRoles: Prof
Matthias Egger
3Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
5Population Health Sciences, Bristol Medical School, University of Bristol, UK
18Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa
Roles: Prof
Roger D Kouyos
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
PhDRoles: Prof
Data Availability
All data produced in the present work are contained in the manuscript or the appendix.
Posted July 21, 2024.
Predicting emergent Dolutegravir resistance in South Africa: A modelling study
Tom Loosli, Anthony Hauser, Johannes Josi, Nuri Han, Suzanne M Ingle, Ard van Sighem, Linda Wittkop, Janne Vehreschild, Francesca Ceccherini-Silberstein, Gary Maartens, M John Gill, Caroline A Sabin, Leigh F Johnson, Richard Lessells, Huldrych F Günthard, Matthias Egger, Roger D Kouyos
medRxiv 2024.07.20.24310740; doi: https://doi.org/10.1101/2024.07.20.24310740
Predicting emergent Dolutegravir resistance in South Africa: A modelling study
Tom Loosli, Anthony Hauser, Johannes Josi, Nuri Han, Suzanne M Ingle, Ard van Sighem, Linda Wittkop, Janne Vehreschild, Francesca Ceccherini-Silberstein, Gary Maartens, M John Gill, Caroline A Sabin, Leigh F Johnson, Richard Lessells, Huldrych F Günthard, Matthias Egger, Roger D Kouyos
medRxiv 2024.07.20.24310740; doi: https://doi.org/10.1101/2024.07.20.24310740
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2970)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12815)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4622)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2942)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (933)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4412)
- Nursing (238)
- Nutrition (652)
- Oncology (2296)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (282)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1200)
- Primary Care Research (503)
- Public and Global Health (7008)
- Radiology and Imaging (1545)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)